SEngine Precision Medicine Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
17
- Latest Deal Type
-
M&A
SEngine Precision Medicine General Information
Description
Operator of an oncology diagnostic firm intended to identify and develop the next generation of cancer-targeted drugs. The company's platform employs functional genomics and robotic testing of drugs in live patient organoids to match newly developed drugs to individual cancer patients, enabling oncologists and healthcare companies to find personalized treatment options.
Contact Information
Website
senginemedicine.com(Operating Subsidiary)
Corporate Office
- 22125 17th Avenue Southeast
- Bothell, WA 98021
- United States
Corporate Office
- 22125 17th Avenue Southeast
- Bothell, WA 98021
- United States
SEngine Precision Medicine Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 03-Oct-2023 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 10-Mar-2023 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A2) | 28-Jul-2022 | Completed | Pre-Clinical Trials | |||
| 3. Debt - PPP | 14-Apr-2020 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC (Series A) | 02-Oct-2019 | $8.65M | $8.65M | Completed | Pre-Clinical Trials | |
| 1. Grant | 02-May-2018 | $755K | Completed | Startup |
SEngine Precision Medicine Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A | 3,000,000 | $0.000100 | $0.31 | $3.87 | $3.87 | 1x | $3.1 | 16.93% |
| Seed | 3,000,000 | $0.000100 | $0.31 | $3.87 | $3.87 | 1x | $3.87 | 13.54% |
SEngine Precision Medicine Comparisons
Industry
Financing
Details
SEngine Precision Medicine Competitors (12)
One of SEngine Precision Medicine’s 12 competitors is Volastra, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Volastra | Venture Capital-Backed | New York, NY | ||||
| Genesis Biotechnology Group | Corporation | Hamilton, NJ | ||||
| Loxo Oncology | Formerly VC-backed | Stamford, CT | ||||
| Xilis | Venture Capital-Backed | Durham, NC | ||||
| Ability Pharma | Private Equity-Backed | Barcelona, Spain |
SEngine Precision Medicine Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
SEngine Precision Medicine Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
SEngine Precision Medicine Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 3rdEyeBio | Accelerator/Incubator | Minority | ||
| Accellius Capital | Venture Capital | Minority | ||
| Alethea Capital Management | Venture Capital | Minority | ||
| Bangarang Group | Angel Group | Minority | ||
| Keiretsu Forum | Angel Group | Minority |
SEngine Precision Medicine Investments (1)
SEngine Precision Medicine’s most recent deal was a Joint Venture with Joint Venture - (SEngine Precision Medicine/Atomwise). The deal was made on 10-Sep-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Joint Venture - (SEngine Precision Medicine/Atomwise) | 10-Sep-2019 | Joint Venture | Biotechnology |
SEngine Precision Medicine FAQs
-
When was SEngine Precision Medicine founded?
SEngine Precision Medicine was founded in 2015.
-
Where is SEngine Precision Medicine headquartered?
SEngine Precision Medicine is headquartered in Bothell, WA.
-
What is the size of SEngine Precision Medicine?
SEngine Precision Medicine has 17 total employees.
-
What industry is SEngine Precision Medicine in?
SEngine Precision Medicine’s primary industry is Drug Delivery.
-
Is SEngine Precision Medicine a private or public company?
SEngine Precision Medicine is a Private company.
-
What is SEngine Precision Medicine’s current revenue?
The current revenue for SEngine Precision Medicine is .
-
How much funding has SEngine Precision Medicine raised over time?
SEngine Precision Medicine has raised $19.2M.
-
Who are SEngine Precision Medicine’s investors?
3rdEyeBio, Accellius Capital, Alethea Capital Management, Bangarang Group, and Keiretsu Forum are 5 of 8 investors who have invested in SEngine Precision Medicine.
-
Who are SEngine Precision Medicine’s competitors?
Volastra, Genesis Biotechnology Group, Loxo Oncology, Xilis, and Ability Pharma are some of the 12 competitors of SEngine Precision Medicine.
-
When was SEngine Precision Medicine acquired?
SEngine Precision Medicine was acquired on 03-Oct-2023.
-
Who acquired SEngine Precision Medicine?
SEngine Precision Medicine was acquired by Tempus AI.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
